These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 25980995)

  • 1. The Impact of Caffeine on the Behavioral Effects of Ethanol Related to Abuse and Addiction: A Review of Animal Studies.
    López-Cruz L; Salamone JD; Correa M
    J Caffeine Res; 2013 Mar; 3(1):9-21. PubMed ID: 24761272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stimulatory effects of caffeine with oseltamivir (Tamiflu) on light-dark behavior and open-field behavior in mice.
    Uchiyama H; Toda A; Imoto M; Nishimura S; Kuroki H; Soeda S; Shimeno H; Watanabe S; Eyanagi R
    Neurosci Lett; 2010 Jan; 469(2):184-8. PubMed ID: 19963037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 8-(furan-2-yl)-3-benzyl thiazolo [5,4-e][1,2,4] triazolo [1,5-c] pyrimidine-2(3H)-thione as selective adenosine A(2A) receptor antagonist.
    Barodia SK; Mishra CB; Prakash A; Senthil Kumar JB; Kumari N; Luthra PM
    Neurosci Lett; 2011 Jan; 488(1):1-5. PubMed ID: 20708066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A1, but not A2, receptor blockade increases anxiety and arousal in Zebrafish.
    Maximino C; Lima MG; Olivera KR; Picanço-Diniz DL; Herculano AM
    Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):203-7. PubMed ID: 21496211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects.
    Paterniti I; Melani A; Cipriani S; Corti F; Mello T; Mazzon E; Esposito E; Bramanti P; Cuzzocrea S; Pedata F
    J Neuroinflammation; 2011 Apr; 8():31. PubMed ID: 21486435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors.
    Antoniou K; Papadopoulou-Daifoti Z; Hyphantis T; Papathanasiou G; Bekris E; Marselos M; Panlilio L; Müller CE; Goldberg SR; Ferré S
    Psychopharmacology (Berl); 2005 Dec; 183(2):154-62. PubMed ID: 16205915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adenosine system in the action of oseltamivir on behavior in mice.
    Uchiyama H; Hiromura M; Shiratani T; Kuroki H; Honda S; Kosako K; Soeda S; Inoue K; Toda A
    Neurosci Lett; 2015 Jul; 599():7-11. PubMed ID: 25980995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Opportunities for Caffeine and A2A Receptor Antagonists in Retinal Diseases.
    Boia R; Ambrósio AF; Santiago AR
    Ophthalmic Res; 2016; 55(4):212-8. PubMed ID: 26959995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypothermic Action of Oseltamivir Not Dependent on Its Anti-influenza Virus Action].
    Ono H
    Yakugaku Zasshi; 2019; 139(5):767-781. PubMed ID: 31061347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of adenosine in intraocular pressure].
    Konno T
    Nihon Yakurigaku Zasshi; 2004 Apr; 123(4):289-94. PubMed ID: 15056945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of A2 adenosine receptor pharmacological regulators in the treatment of cardiovascular diseases, recent progress, and prospective.
    Bahreyni A; Avan A; Shabani M; Ryzhikov M; Fiuji H; Soleimanpour S; Khazaei M; Hassanian SM
    J Cell Physiol; 2019 Feb; 234(2):1295-1299. PubMed ID: 30146778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coffee and cancer].
    Franco R
    Med Clin (Barc); 2008 Nov; 131(16):633-5. PubMed ID: 19080856
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.